Quick Answer
Sunshine Biopharma Inc. reported Stockholders Equity of $23.50 million for fiscal year 2024.
Sunshine Biopharma Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | $23.50M | +10.8% |
| 2023 | $21.21M | -1.9% |
| 2022 | $21.63M | +10118.0% |
| 2021 | $211.7K | +122.2% |
| 2020 | -$954.8K | -29.8% |
| 2019 | -$735.4K | -1219.0% |
| 2018 | -$55.8K | +90.3% |
| 2017 | -$573.4K | -173.4% |
| 2016 | -$209.7K | +64.9% |
| 2015 | -$597.0K | -54.0% |
| 2014 | -$387.6K | -4927.0% |
| 2013 | -$7.7K | -110.9% |
| 2012 | $70.4K | -31.6% |
| 2011 | $103.0K | -47.5% |
| 2010 | $196.2K | +100.6% |
| 2009 | $97.8K | -70.9% |
| 2009 | $336.1K | — |
| 2009 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $24.20M | -3.4% | -5.8% |
| June 30, 2025 | $25.68M | +9.3% | +13.1% |
| March 31, 2025 | $22.70M | -8.5% | -3.4% |
| December 31, 2024 | $23.50M | +10.8% | -6.1% |
| September 30, 2024 | $25.04M | +14.0% | +6.6% |
| June 30, 2024 | $23.49M | +1.6% | -5.4% |
| March 31, 2024 | $24.82M | +27.7% | +17.0% |
| December 31, 2023 | $21.21M | -1.9% | -3.4% |
- Sunshine Biopharma Inc. showed an increase of +10.8% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from Sunshine Biopharma Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 1, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: